LCN2 and acute kidney injury: The proposed biomarkers include tissue damage markers such as TIMP2/IGFBP7 (combination of tissue inhibitor of metalloproteinases 2 and insulin-like growth factor binding protein) and NGAL (neutrophil gelatinase-associated lipocalin) in patients at high risk of surgery-associated AKI.